Материалов:
1 082 141

Репозиториев:
30

Авторов:
761 409

По вашему запросу найдено документов: 456

Страница 1 из 46

An open-label extension of a phase 2 dose-finding study of once-weekly somatrogon vs. once-daily Genotropin in children with short stature due to growth hormone deficiency: results following 5 years of treatment
Zadik, Zvi, Zelinska, Nataliya, Iotova, Violeta, Skorodok, Yulia, Malievsky, Oleg, Mauras, Nelly, Valluri, Srinivas Rao, Pastrak, Aleksandra, Rosenfeld, Ron
EFFICACY OF ONCE-WEEKLY ADMINISTRATION OF CTP-MODIFIED HUMAN GROWTH HORMONE (MOD-4023): 24-MONTH COMPLETE DATABASE RESULTS OF A PHASE 2 STUDY IN CHILDREN WITH GROWTH HORMONE DEFICIENCY
Zelinska, N., Skorodok, J., Skorodok, J., Malievsky, O., Rosenfeld, R.G., Zadik, Z., Koren, R., Vander, S., Hart, G., Raduk, D.
EFFICACY OF ONCE-WEEKLY ADMINISTRATION OF CTP-MODIFIED HUMAN GROWTH HORMONE (MOD-4023): 24-MONTH COMPLETE DATABASE RESULTS OF A PHASE 2 STUDY IN CHILDREN WITH GROWTH HORMONE DEFICIENCY
Zelinska, N., Skorodok, J., Skorodok, J., Malievsky, O., Rosenfeld, R.G., Zadik, Z., Koren, R., Vander, S., Hart, G., Raduk, D.
Signal, sympathetic action of succinate in experimental and clinical studies
Maevsky, E. I., Rosenfeld, A. S., Peskov, A. B., Kondrashova, M. N.
Signal, sympathetic action of succinate in experimental and clinical studies
Maevsky, E. I., Rosenfeld, A. S., Peskov, A. B., Kondrashova, M. N.
LONG-ACTING C-TERMINAL PEPTIDE-MODIFIED HGH (MOD-4023): RESULTS OF A SAFETY AND DOSE-FINDING STUDY IN GHD CHILDREN
Zelinska, N., Iotova, V., Skorodok, J., Malievsky, O., Peterkova, V., Samsonova, L., Rosenfeld, Ron G., Zadik, Zvi, Jaron-Mendelson, Michal, Koren, Ronit, Amitzi, Leanne, Raduk, Dmitri, Hershkovitz, Oren, Hart, Gili
LONG-ACTING C-TERMINAL PEPTIDE-MODIFIED HGH (MOD-4023): RESULTS OF A SAFETY AND DOSE-FINDING STUDY IN GHD CHILDREN
Zelinska, N., Iotova, V., Skorodok, J., Malievsky, O., Peterkova, V., Samsonova, L., Rosenfeld, Ron G., Zadik, Zvi, Jaron-Mendelson, Michal, Koren, Ronit, Amitzi, Leanne, Raduk, Dmitri, Hershkovitz, Oren, Hart, Gili
SAFETY AND TOLERABILITY OF ONCE-WEEKLY ADMINISTRATION OF CTP-MODIFIED HUMAN GROWTH HORMONE (MOD-4023): 24-MONTH COMPLETE DATASET RESULTS OF A PHASE 2 STUDY IN CHILDREN WITH GROWTH HORMONE DEFICIENCY
Zelinska, N., Skorodokb, J., Malievsky, O., Rosenfeldd, Ron G., Zadike, Zvi, Korenf, R., Vanderf, Sh., Hartf, G., Radziukg, K.
SAFETY AND TOLERABILITY OF ONCE-WEEKLY ADMINISTRATION OF CTP-MODIFIED HUMAN GROWTH HORMONE (MOD-4023): 24-MONTH COMPLETE DATASET RESULTS OF A PHASE 2 STUDY IN CHILDREN WITH GROWTH HORMONE DEFICIENCY
Zelinska, N., Skorodokb, J., Malievsky, O., Rosenfeldd, Ron G., Zadike, Zvi, Korenf, R., Vanderf, Sh., Hartf, G., Radziukg, K.
Oxidation of proteins: is it a programmed process?
Rosenfeld Mark A.

Страница 1 из 46

Фасеты

Партнеры

КФУ
ТГУ
Elpub
СФУ
Webpublishers

Индексация

BASE
WorldCat
OpenAIRE
EDS
core